{
  "drugs": [
    {
      "drug_id": "DRUG001",
      "generic_name": "Metformin",
      "brand_names": ["Glucophage", "Fortamet", "Glumetza", "Riomet"],
      "drug_class": "Biguanide",
      "therapeutic_category": "Antidiabetic Agent",
      "mechanism_of_action": "Decreases hepatic glucose production, decreases intestinal absorption of glucose, improves insulin sensitivity",
      "indications": [
        "Type 2 diabetes mellitus",
        "Prediabetes (off-label)",
        "Polycystic ovary syndrome (off-label)"
      ],
      "dosage_forms": [
        {
          "form": "Tablet",
          "strengths": ["500mg", "850mg", "1000mg"],
          "route": "Oral"
        },
        {
          "form": "Extended-release tablet", 
          "strengths": ["500mg", "750mg", "1000mg"],
          "route": "Oral"
        },
        {
          "form": "Oral solution",
          "strengths": ["500mg/5mL"],
          "route": "Oral"
        }
      ],
      "typical_dosing": {
        "initial_dose": "500mg twice daily with meals",
        "maximum_dose": "2550mg daily",
        "titration": "Increase by 500mg weekly based on tolerability"
      },
      "contraindications": [
        "Severe renal impairment (eGFR < 30 mL/min/1.73mÂ²)",
        "Acute or chronic metabolic acidosis",
        "Diabetic ketoacidosis",
        "Severe heart failure requiring pharmacologic treatment"
      ],
      "side_effects": {
        "common": [
          "Gastrointestinal upset",
          "Nausea", 
          "Diarrhea",
          "Abdominal pain",
          "Metallic taste"
        ],
        "serious": [
          "Lactic acidosis (rare)",
          "Vitamin B12 deficiency (long-term use)"
        ]
      },
      "drug_interactions": [
        {
          "drug": "Alcohol",
          "interaction": "Increased risk of lactic acidosis",
          "severity": "Major"
        },
        {
          "drug": "Iodinated contrast media",
          "interaction": "Increased risk of lactic acidosis and acute kidney injury",
          "severity": "Major"
        },
        {
          "drug": "Carbonic anhydrase inhibitors",
          "interaction": "Increased risk of lactic acidosis",
          "severity": "Moderate"
        }
      ],
      "monitoring_parameters": [
        "Renal function (eGFR)",
        "Vitamin B12 levels (annually)",
        "Liver function tests",
        "HbA1c",
        "Fasting glucose"
      ]
    },
    {
      "drug_id": "DRUG002",
      "generic_name": "Atorvastatin",
      "brand_names": ["Lipitor", "Atorlip", "Atocor"],
      "drug_class": "HMG-CoA Reductase Inhibitor (Statin)",
      "therapeutic_category": "Antilipemic Agent",
      "mechanism_of_action": "Inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis",
      "indications": [
        "Primary hypercholesterolemia",
        "Mixed dyslipidemia",
        "Primary prevention of cardiovascular disease",
        "Secondary prevention of cardiovascular disease"
      ],
      "dosage_forms": [
        {
          "form": "Tablet",
          "strengths": ["10mg", "20mg", "40mg", "80mg"],
          "route": "Oral"
        }
      ],
      "typical_dosing": {
        "initial_dose": "20mg once daily",
        "maximum_dose": "80mg once daily",
        "titration": "May increase after 2-4 weeks based on lipid response"
      },
      "contraindications": [
        "Active liver disease",
        "Unexplained persistent elevations in hepatic transaminases",
        "Pregnancy",
        "Nursing mothers"
      ],
      "side_effects": {
        "common": [
          "Headache",
          "Myalgia", 
          "Diarrhea",
          "Nausea",
          "Fatigue"
        ],
        "serious": [
          "Rhabdomyolysis",
          "Hepatotoxicity",
          "Diabetes mellitus (new-onset)"
        ]
      },
      "drug_interactions": [
        {
          "drug": "Cyclosporine",
          "interaction": "Increased atorvastatin exposure, increased risk of myopathy",
          "severity": "Major"
        },
        {
          "drug": "Gemfibrozil",
          "interaction": "Increased risk of rhabdomyolysis",
          "severity": "Major"
        },
        {
          "drug": "Warfarin",
          "interaction": "Increased anticoagulant effect",
          "severity": "Moderate"
        }
      ],
      "monitoring_parameters": [
        "Lipid panel",
        "Liver function tests (baseline and as needed)",
        "Creatine kinase (if symptoms of myopathy)",
        "Blood glucose (baseline and periodically)"
      ]
    },
    {
      "drug_id": "DRUG003",
      "generic_name": "Aspirin",
      "brand_names": ["Bayer Aspirin", "Bufferin", "Ecotrin"],
      "drug_class": "Nonsteroidal Anti-inflammatory Drug (NSAID)",
      "therapeutic_category": "Analgesic, Anti-inflammatory, Antiplatelet",
      "mechanism_of_action": "Irreversibly inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), reducing prostaglandin synthesis",
      "indications": [
        "Pain relief (mild to moderate)",
        "Fever reduction",
        "Inflammation",
        "Cardiovascular disease prevention",
        "Stroke prevention",
        "Acute coronary syndrome"
      ],
      "dosage_forms": [
        {
          "form": "Tablet",
          "strengths": ["81mg", "325mg", "500mg"],
          "route": "Oral"
        },
        {
          "form": "Enteric-coated tablet",
          "strengths": ["81mg", "325mg"],
          "route": "Oral"
        },
        {
          "form": "Chewable tablet",
          "strengths": ["81mg"],
          "route": "Oral"
        }
      ],
      "typical_dosing": {
        "cardiovascular_prevention": "81mg once daily",
        "analgesic": "325-650mg every 4 hours as needed",
        "anti_inflammatory": "2400-3600mg daily in divided doses"
      },
      "contraindications": [
        "Hypersensitivity to aspirin or NSAIDs",
        "Active peptic ulcer disease",
        "Severe renal impairment",
        "Severe heart failure",
        "Children under 16 with viral infections (Reye's syndrome risk)"
      ],
      "side_effects": {
        "common": [
          "Gastrointestinal irritation",
          "Nausea",
          "Dyspepsia",
          "Abdominal pain"
        ],
        "serious": [
          "Gastrointestinal bleeding",
          "Peptic ulcer",
          "Intracranial hemorrhage",
          "Reye's syndrome (in children)",
          "Severe allergic reactions"
        ]
      },
      "drug_interactions": [
        {
          "drug": "Warfarin",
          "interaction": "Increased bleeding risk",
          "severity": "Major"
        },
        {
          "drug": "Methotrexate",
          "interaction": "Increased methotrexate toxicity",
          "severity": "Major"
        },
        {
          "drug": "ACE inhibitors",
          "interaction": "Reduced antihypertensive effect",
          "severity": "Moderate"
        }
      ],
      "monitoring_parameters": [
        "Signs of bleeding",
        "Renal function",
        "Liver function (with high doses)",
        "Complete blood count (with long-term use)"
      ]
    }
  ],
  "drug_relationships": [
    {
      "relationship_type": "treats_same_condition",
      "drug1": "Metformin",
      "drug2": "Insulin",
      "condition": "Type 2 Diabetes Mellitus",
      "notes": "Often used together in combination therapy"
    },
    {
      "relationship_type": "contraindicated_combination", 
      "drug1": "Aspirin",
      "drug2": "Warfarin",
      "reason": "Increased bleeding risk",
      "severity": "Major"
    },
    {
      "relationship_type": "synergistic_effect",
      "drug1": "Aspirin",
      "drug2": "Atorvastatin", 
      "condition": "Cardiovascular Disease Prevention",
      "notes": "Complementary mechanisms for cardiovascular protection"
    }
  ]
}